2,000
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2027
Study Completion Date
May 1, 2028
Community screening for hepatitis B, C and delta in the Mongolian population living in France
"Screening will be organised in 11 centres in France, with 1 to 3 screening sessions per centre: patients will be informed of these screening sessions by the Mongolian Embassy in France, social networks and communities.~During this screening visit, Rapid Diagnostic Orientation Test (RDOT) will be carried out to screen for HBV and HCV. If the RDOT is negative for both viruses, an information on transmission and prevention of viral infection will be given.~If the RDOT is positive, confirmation of these tests by blood sampling will be organized and complementary biology (ASAT, ALAT, GGT, PAL, bilirubin total, bilirubin conjugated). If HBV RDOT positive, additional tubes will be collected for centralized analysis at the end of the study (VHD DNA, VHD genotyping, fibrotest and LCR1/2 test).~Once these confirmatory tests have been carried out, the patient will be referred to a hepatology consultation."
Centre Hospitalier Annecy Genevois, Annecy
Centre Expert Hépatites Virales Aquitaine, CHU de Bordeaux, Bordeaux
CHU de Clermont Ferrand, Clermont-Ferrand
Hôpital Henri Mondor - Assistante Publique Hopitaux de Paris (APHP), Créteil
CHU Grenoble Alpes, Grenoble
CHRU Lille, Lille
Service d'Hépatologie, Institut d'hépatologie de Lyon, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon
CHRU Rennes Pontchaillou, Rennes
CHU de Rouen, Rouen
Hôpitaux Universitaires de Strasbourg, Strasbourg
CHRU Bretonneau, Tours
Hospices Civils de Lyon
OTHER